A Comprehensive Review on Postpartum Depression
- PMID: 36686097
- PMCID: PMC9851410
- DOI: 10.7759/cureus.32745
A Comprehensive Review on Postpartum Depression
Abstract
One of the most common psychological effects following childbirth is postpartum depression. Postpartum depression (PPD) has a significant negative impact on the child's emotional, mental as well as intellectual development if left untreated, which can later have long-term complications. Later in life, it also results in the mother developing obsessive-compulsive disorder and anxiety. Many psychological risk factors are linked with PPD. The pathophysiology of the development of PPD is explained by different models like biological, psychological, integrated, and evolutionary models, which relate the result of the condition with particular conditions and factors. This article also explains the role of methyldopa as a medication used during pregnancy and the postpartum phase with the development of PPD. There are different mechanisms by which methyldopa causes depression. The large-scale screening of the condition can be done by Edinburgh Postnatal Depression Scale (EPDS). The diagnosis can be made by clinical assessment, simple self-report instruments, and questionnaires provided to mothers. Currently, there has not been any specific treatment for PPD, but selective serotonin reuptake inhibitors (SSRIs) like sertraline are effective in acute management. Venlafaxine and desvenlafaxine are serotonin-norepinephrine reuptake inhibitors used for the relief of symptoms. The SSRI and tricyclic antidepressants (TCA) used in combination have a prophylactic role in PPD. Nowadays, women prefer psychological therapies, complementary health practices, and neuromodulatory interventions like electroconvulsive therapy more than previous pharmacological treatments of depression. Allopregnanolone drug made into sterile solution brexanolone leads to a rapid decline of PPD symptoms. PPD is a common and severe disorder that affects many mothers following childbirth but is ignored and not given much importance. Later it affects the child's psychological and intellectual abilities and mother-child bonding. We can easily prevent it by early diagnosis and timely care and management of the mother. Understanding the underlying pathophysiology would also go a long way in preventing and managing the disorder.
Keywords: antidepressants; mental health; methyldopa; postpartum depression; psychological.
Copyright © 2022, Suryawanshi et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Postpartum depression: current status and future directions. O’Hara MW, McCabe JE. Annu Rev Clin Psychol. 2013;9:379–407. - PubMed
-
- Bipolar disorder in the postpartum period: management strategies and future directions. Pope CJ, Sharma V, Mazmanian D. Womens Health (Lond) 2014;10:359–371. - PubMed
-
- Genève, Switzerland: World Health Organization; 1992. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines.
-
- The DSM-5 peripartum specifier: prospects and pitfalls. Sharma V, Mazmanian D. Arch Womens Ment Health. 2014;17:171–173. - PubMed
Publication types
LinkOut - more resources
Full Text Sources